Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Megace (Megestrol Acetate, USP) Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2012

Summary View

 

PRECAUTIONS

Use In Women (previously named “Use in HIV-Infected Women” and relocated to PRECAUTIONS)

  • Megace is a progesterone derivative, which may induce vaginal bleeding in women

 

-
-